G

GSK

GSK PLC

54.82

+0.60+1.10%
Opening11:03 04/28 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Cash from Operating Activities

7.75B

6.56B

6.77B

7.59B

7.96B

Net Income

6.29B

2.95B

5.31B

4.92B

5.10B

Depreciation/Depletion & Amortization

2.31B

2.55B

2.29B

2.15B

2.38B

Deferred Taxes

--

--

--

--

--

Non-Cash Items

3.11B

1.51B

1.99B

2.62B

1.26B

Changes in Working Capital

-3.97B

-452.00M

-2.83B

-2.10B

-773.00M

Cash from Investing Activities

-4.23B

-1.23B

-1.59B

-8.77B

-1.78B

Capital Expenditures

-2.98B

-2.98B

-2.34B

-2.26B

-2.93B

Other Investing Cash Flow Items, Total

-1.25B

1.75B

749.00M

-6.51B

1.15B

Cash from Financing Activities

-3.69B

-4.73B

-5.64B

823.00M

-7.59B

Financing Cash Flow Items

-1.02B

-910.00M

-837.00M

9.09B

-1.40B

Total Cash Dividends Paid

-2.56B

-2.44B

-2.25B

-3.47B

-4.00B

Issuance (Retirement) of Stock, Net

-1.36B

20.00M

10.00M

25.00M

21.00M

Issuance (Retirement) of Debt, Net

1.26B

-1.39B

-2.57B

-4.82B

-2.21B

Foreign Exchange Effects

-19.00M

-54.00M

-99.00M

152.00M

-29.00M

Net Change in Cash

-196.00M

545.00M

-567.00M

-394.00M

-1.44B

Cash Interest Paid

679.00M

632.00M

766.00M

848.00M

786.00M

Cash Taxes Paid

1.20B

1.31B

1.33B

1.31B

1.29B